Nihms 817138
Nihms 817138
Nihms 817138
Author manuscript
Neuropsychol Rev. Author manuscript; available in PMC 2017 September 08.
Author Manuscript
Abstract
Cognitive interventions in Mild Cognitive Impairment (MCI) seek to ameliorate cognitive
symptoms in the condition. Cognitive interventions may or may not generalize beyond cognitive
outcomes to everyday life. This systematic review and meta-analysis sought to assess the effect of
cognitive interventions compared to a control group in MCI on generalizability outcome measures
[activities of daily living (ADLs), mood, quality of life (QOL), and metacognition] rather than
cognitive outcomes alone. PRISMA guidelines were followed. MEDLINE and PsychInfo were
utilized as data sources to locate references related to cognitive interventions in individuals with
MCI. The cognitive intervention study was required to have a control or alternative treatment
comparison group to be included. Thirty articles met criteria, including six computerized cognitive
interventions, 14 therapist-based interventions, and 10 multimodal (i.e., cognitive intervention plus
an additional intervention) studies. Small, but significant overall median effects were seen for
Author Manuscript
ADLs (d = 0.23), mood (d = 0.16), and metacognitive outcomes (d = 0.30), but not for QOL (d =
0.10). Computerized studies appeared to benefit mood (depression, anxiety, and apathy) compared
to controls, while therapist-based interventions and multimodal interventions had more impact on
ADLs and metacognitive outcomes than control conditions. The results are encouraging that
cognitive interventions in MCI may impact everyday life, but considerably more research is
needed. The current review and meta-analysis is limited by our use of only PsychInfo and
MEDLINE databases, our inability to read full text non-English articles, and our reliance on only
published data to complete effect sizes.
Keywords
Mild Cognitive Impairment; Cognitive intervention; Activities of daily living; Quality of life;
Author Manuscript
Introduction
Research into interventions for Mild Cognitive Impairment (MCI) has been growing
exponentially since the turn of the twenty-first century. The concept of MCI was formulated
almost 20 years ago now (Petersen et al. 1999; Smith et al. 1996) to help focus research and
clinical practice on people at risk for but having not yet developed dementia. MCI is
Author Manuscript
MCI was once viewed as a condition that was not conducive for rehabilitation because of its
likely progressive course to dementia. However, there has been increasing interest in
whether individuals with MCI can benefit from cognitive intervention and rehabilitation
techniques. A cognitive intervention is an intervention aimed to positively impact the
cognitive functioning of an individual. To further operationalize types of cognitive
Author Manuscript
interventions, Linda Clare and her colleagues (2003) advocate distinguishing the concepts of
cognitive stimulation, cognitive training, and cognitive rehabilitation. Cognitive stimulation
usually refers to activities that are not aimed towards a systematic improvement of a
particular cognitive domain, but rather cognitive activity that is thought to be “stimulating”
and good for the brain in general. Cognitive training usually involves manualized training to
aid function in a particular cognitive domain, such as memory, language, or problem solving.
Cognitive rehabilitation usually refers to a more individualized approach based on goal
setting with the person and often their family member(s). Several early reviews into
cognitive interventions in MCI were published between 2008 and 2012, including a
Cochrane Review of published randomized controlled trials (RCT) through 2007 that found
little evidence for the benefit of cognitive interventions in MCI (Martin et al. 2011). Less
strict reviews (i.e., those not requiring RCTs at that early stage of the field) were more
Author Manuscript
positive, noting hopeful outcomes on cognition, mood, and daily life after cognitive
rehabilitation (e.g., Tsolaki et al. 2011; Gates et al. 2011).
Repeatedly, these reviews pointed to a need for larger trials, randomized control groups, and
consistency in outcomes measured (Belleville 2008; Jean et al. 2010a; Stott and Spector
2011; Hampstead et al. 2014). The few reviews that set out to perform meta-analyses were
stymied by the wide variety of methods employed in the cognitive interventions and variable
outcomes measured (e.g., Gates et al. 2011; Kurz et al. 2011; Cooper et al. 2013). Li et al.
(2011) did perform a meta-analysis on studies containing either a cognitive or functional
outcome but not all of the studies were controlled trials (CTs). They found a moderate
impact on language (d = 0.51), episodic memory (0.45), anxiety (0.51), and functional
ability (0.55), but little effect on other areas of cognition, quality of life (QOL), or
Author Manuscript
depression. They noted, as have others (Martin et al. 2011), that the effect sizes were smaller
in the controlled studies compared to the single arm studies.
Few reviews have looked at the everyday impact of cognitive interventions in MCI, and
some have even required a cognitive outcome measure for inclusion in the review (e.g.,
Reijnders et al. 2013). Lack of focus on real-world impact outcomes appears to be
particularly true in computer-based interventions (Lampit et al. 2014). While requiring a
cognitive outcome in a cognitive intervention trial may at first seem straight forward, the
underlying assumption is that cognitive interventions in MCI are meant to ameliorate decline
Author Manuscript
or even restore cognitive ability. However, the goals of cognitive interventions or cognitive
rehabilitation are not exclusively meant to restore cognition. In rehabilitation, the focus can
be on impacting the ability itself by returning it to its baseline (restorative) or at least
improving it to some degree (remediation), or the focus can be on helping an individual
adapt to the changed ability without attempting to improve the ability itself (compensation).
Both can be addressed in rehabilitation simultaneously as well.
In the case of MCI due to a neurodegenerative condition, the pathological burden in the
brain by time of symptom onset is often substantial. Restoring innate memory or other
cognitive ability at this point may not be feasible. Rather, the goal may often be
compensation or adaptation to a lost ability, where no improvement in measured cognitive
ability is expected. Thus, while some reviews may find moderate to large effect sizes for
memory outcomes (e.g., Gates et al. 2011), it is not surprising that some reviews find little
Author Manuscript
impact on standardized neuropsychological tests (e.g., Simon et al. 2012; Cooper et al.
2013).
measures to “secondary outcomes” or “other treatment targets” behind the primary cognitive
outcomes. This is unfortunate, as individuals with MCI and their partners have been shown
to report quality of life and self-efficacy as the most important outcomes they want to see
addressed in cognitive intervention programs (Barrios et al. 2016).
Giebel and Challis (2015) searched the literature in May of 2013 and found only three
cognitive intervention studies in MCI that had an everyday functional ability outcome. These
authors noted that while these three studies were encouraging that cognitive training could
improve ADLs in MCI, the studies lacked clear descriptions of the interventions, apparent
non-standardized administration of the interventions, and weak theoretical rationale for
choice of cognitive strategy. This undermined the interpretability of the impact of cognitive
training on ADLs in MCI. Coyle et al. (2015) focused their systematic review on
Author Manuscript
computerized interventions through January 2014 and found that eight of sixteen studies
looked at mood and ADLs as secondary outcomes, and five of sixteen looked at
metacognitive outcomes. Mood improvements were noted in a little under half of the
computerized interventions that assessed mood, but none of the eight studies that looked at
ADLs found change after the computerized intervention. This may be expected, as
computerized interventions are usually remediation based rather than compensation based,
and thus cognitive outcomes were more likely to show improvement.
The growth of cognitive intervention studies in MCI from the first published RCT in 2002
Author Manuscript
(Rapp et al.) to the date of this review is show in Fig. 1. Given the significant growth of
research in this area, and the dearth of reviews targeting daily life outcomes after cognitive
intervention in MCI, we sought to determine if there had been a recent increase in the
utilization of everyday outcomes in cognitive intervention trials in MCI. We focused our
search on studies that compared everyday or “generalizability” outcomes in individuals with
MCI who had received a cognitive intervention contrasted to a comparison group. We
defined generalizability outcomes not as measured change in cognition, but rather the
impacts on daily life to which the cognitive interventions may generalize or transfer.
Specifically, this includes outcomes such as measures of ADLs, mood, QOL, or
metacognitive outcomes (how one feels/thinks about one’s cognitive process). We organized
these studies based upon what type of intervention was administered. Namely, studies were
presented in groups of computerized interventions (where the goal is most often cognitive
Author Manuscript
Methods
Search Strategy
PRISMA guidelines were followed (Moher et al. 2009); however, the protocol was not
registered. Using the Ovid interface, an experienced librarian searched the MEDLINE and
PsychInfo databases based on the PICOS statement provided by the authors. Both searches
were completed on October 30, 2015 and included all possible publications up until that
date. There were no restrictions on language or publication date; however, the searches were
Author Manuscript
limited to adult participants. Search strategy included MeSH and PsychInfo controlled
vocabulary terms and keywords, including Mild Cognitive Impairment, MCI, cognitive
therapy, and rehabilitation. The complete strategy can be found in the Appendix.
was not peer reviewed, 5) the sample included MCI, but was mixed with healthy elderly
and/or dementia subjects and independent analysis of the MCI group was not provided, 6)
the study was not a CT (either CTs or RCTs were acceptable), 7) there was no generalization
outcome (e.g., only objective cognitive testing outcome), 8) the sample was a duplicate of
another published paper without novel information (additional studies from the same sample
were included if they represented an additional follow up point or different outcome
variables), and 9) the status could not be determined because the article was not in English
(all had English abstracts and some could be excluded prior to this ninth criteria based upon
Author Manuscript
that abstract).
Titles were first reviewed for obvious exclusions. If it was unclear whether the article should
be excluded after reading the abstract, the full text was reviewed. Authors MJC and GES
then compared their reviews of articles to ensure that the same studies had been excluded or
included in the order of priority listed above. No metric of inter-rater reliability was
assessed. Any discrepancies between the two authors were discussed, the full text articles
consulted as needed, and an agreement reached on how to best classify the article. The
application of these criteria assured that all studies included in this analysis were clinical
trials involving generalization outcomes from cognitive or multimodal interventions
delivered to exclusively MCI cohorts compared to a control/comparison group that were
presented in a peer reviewed English language publication.
Author Manuscript
Meta-Analysis
Author Manuscript
Meta-analysis was conducted (by MM and LJR) on all studies that included a comparison
group that allowed us to isolate the unique effect of a particular treatment (e.g., no contract
control, social contact control, or alternative treatment). Meta-analysis was restricted to
available data in published manuscripts. Data was extracted from the articles (LJR) to
calculate effect sizes for further use in the meta-analysis (MM). The variables utilized to
calculate effect sizes are presented in Tables 2, 4, and 6. To provide a conservative test of
effect, we used the most distal follow-up occasion available for each study; thus, if a study
had an immediate posttest and 6- and 12-month follow-ups, only the 12-month follow-up
was considered. For most studies, we quantified effect size as standardized mean difference
(Cohen’s d), using the formula:
Author Manuscript
This approach quantified the metric of change in terms of the original variability of the
sample (so that a d = 1 would mean that the treatment group experienced one standard
deviation more improvement than control). For all studies, standardized mean differences
were coded so that positive values meant that the treatment group experienced more
improvement (i.e., in the desirable direction) than the controls.
Following the recommendations of Field and Gillett (2010) we used random effects models
Author Manuscript
to assess the magnitude of effects; generally speaking, random effects permit the
generalization of findings beyond the specific sample of articles included in this study.
Heterogeneity was quantified both in terms of the Q statistic, and tau squared (Hedges and
Olkin 1985; Higgins and Thompson 2002; Higgins et al. 2003). To evaluate the effect of
categorical moderator variables (i.e., therapy modality and outcome type) on effect sizes, we
conducted a multiple regression via mixed model. The model assumed a general linear
model in which each effect size could be predicted from the moderator, which was coded via
dummy coded contrast weights, and which was estimated via generalized least squares
(Field 2003; Overton 1998).
We also attempted quantitative estimates of the extent to which effect size estimates might
show evidence of publication bias. Several methods were used to assess the magnitude of
estimated publication bias and its impact on meta-analysis findings. First, for each group of
Author Manuscript
studies, we estimated Rosenthal’s (1979) Fail Safe N, which estimates the number of
unpublished studies that would need to exist to turn a significant population effect size
estimate into a non-significant one. Second, we employed the Begg and Mazumdar’s (1994)
rank correlation test for publication bias, which estimates Kendall’s tau between a
standardized form of the effect size and its associated variance; when the relationship is
strong/significant, this signifies publication bias (Field and Gillett 2010). However, since the
test lacks power for small meta-analyses, non-significant associations cannot be taken as
evidence for the absence of bias. Third, we employed a sensitivity analysis approach
described by Vevea and Woods (2005), which produces adjusted effect size estimates. This
approach specifies four typical weight functions to adjust effect sizes, which they label
“moderate one-tailed selection,” “severe one-tailed selection,” “moderate two-tailed
selection,” and “severe two-tailed selection.”
Author Manuscript
Results
The initial search terms resulted in 463 articles for further review. Following the article
inclusion/exclusion process (Fig. 2), 30 articles remained for inclusion. Of these, six were
computerized interventions, 14 were therapist-based interventions, and 10 multimodal
studies. In the multimodal studies, cognitive outcomes compared to a control group could be
extracted from one additional computerized (Fiatarone Singh et al. 2014) and two additional
therapist-based interventions (Lam et al. 2015; Nakatsuka et al. 2015). Thus, aspects of these
studies appear in both analyses: the isolated cognitive intervention outcomes in the
respective computerized or therapist-based intervention sections, and the cognitive
intervention outcomes when combined with other nonpharmacological interventions in the
Author Manuscript
multi-modal section.
but it is unlikely that randomization was used given the notably unbalanced group sizes.
Author Manuscript
Recruitment rates were not routinely reported. For those studies utilizing some
approximation of CONSORT reporting guidelines (Schulz et al. 2010) recruitment rates
ranges from 4.5 % (Fiatarone Singh et al. 2014; Hughes et al. 2014) for community samples
to 33 % (Gagnon and Belleville 2012) for a clinical sample (M = 37.8; SD = 36.8). Pooled
(intervention and control) retention rates ranged from 64 % (Maurice Finn and McDonald
2011) to 100 % (Hughes et al.; M = 86.3; SD = 35.1).
Author Manuscript
Sessions lasted from two weeks (Gagnon and Belleville 2012) to nine months (Rozzini et al.
2007), with a median of 25.5 h of intervention (range: 6–130). For four of seven studies, the
last follow-up was end-of-treatment. Three studies (Fiatarone Singh et al. 2014; Gaitan et al.
2013; Hughes et al. 2014) ended treatment after 12 to 26 weeks but conducted delayed
follow-ups at 12 to18 months. The longest follow-up period reported was 18 months
(Fiatarone Singh et al. 2014).
Group intervention was used in three studies while individual interventions were provided in
four studies. Training programs targeting multiple cognitive domains were used in five of
seven studies. Focused attention training was used in Gagnon and Belleville’s (2012) study.
Hughes et al. (2014) used a computer gaming intervention (Wii video games) that required
not only attention but also movement.
Author Manuscript
SD = 19.6). Attrition rates averaged 17.7 % (SD = 7.4), for a total retained sample size
ranging from 65.2 to 90.9 %.
Sessions lasted from three weeks (Jean et al. 2010b) to 12 months (Lam et al. 2015). Hours
of contact could be calculated in 12 of the 14 studies (excludes Finn and McDonald 2015;
Rojas et al. 2013), ranging from 4.5 (Jean et al. 2010b) to 156 h (Lam et al. 2015).
Excluding Lam et al. as an outlier, studies averaged 15.5 h of intervention (SD = 10.1).
Participants were followed through training end in six of the 14 studies, and often the
waitlist control group was then allowed to participate in the intervention (Belleville et al.
Author Manuscript
2006; Brum et al. 2009; Kinsella et al. 2009; Konsztowicz et al. 2013; Troyer et al. 2008).
The longest follow-up period reported was 28 months (Buschert et al. 2012).
The majority of the therapist-based intervention studies (11/14) utilized a group setting for
their intervention, only three studies (Finn and McDonald 2015; Greenaway et al. 2013; Jean
et al. 2010b) had solely individual sessions. Nakatsuka et al. (2015) had both group and in-
home individual sessions. In terms of the therapy content, two studies focused exclusively
on one specific type of learning strategy: repetition lag training (Finn and McDonald 2015)
or errorless learning (Jean et al. 2010b). One study focused exclusively on training of an
external memory (calendar) aid (Greenaway et al. 2013). Konsztowicz et al. (2013)
contrasted a mnemonic memory training group, external aid calendar group, and a waitlist
control. All the remaining studies (10/14) had a multicomponent “memory training” group
that typically consisted of education about memory and memory loss, cognitive exercises,
Author Manuscript
mnemonic training, as well as encouragement to use external aids without detailed training.
Of the 10 multimodal intervention studies reviewed, seven were RCTs and three were CTs.
The study by Reuter et al. (2012) did not include a CG, and instead analyzed subjects
Author Manuscript
Recruitment rates were examined in 7 of 10 studies (excludes Kurz et al. 2009; Hwang et al.
2012; Reuter et al. 2012). Rates ranged from 4.8 % (Fiatarone Singh et al. 2014) to 89.8 %
(Tsolaki et al. 2011) of approached participants (M = 54.4 %; SD = 31.2). The former study
was a clear outlier; in that study a large participant pool (N = 2094) was approached and
only 100 eligible enrolled (4.8 %). Excluding this study, the average enrollment rate is
Author Manuscript
64.3 % (SD = 21.9 %). Two studies (Kurz et al. 2009; Tsolaki et al. 2011) did not publish
data on participants lost to attrition. The average participant retention rate was 85.7 % (SD =
9.0 %).
The average duration of intervention was 16.6 weeks (SD = 14.2) and ranged from 4 weeks
(Kurz et al. 2009; Reuter et al. 2012) to 52 weeks (Lam et al. 2015). An average of 52.2 h of
intervention (SD = 49.0) was delivered across the 10 studies. Five studies (Fiatarone Singh
et al. 2014; Hwang et al. 2012; Joosten-Weyn Banningh et al. 2011; Law et al. 2014; Reuter
et al. 2012) provided data from post-intervention follow-up assessments with intervals
Author Manuscript
ranging from two to 52 weeks (M = 23.0, SD = 15.6), and Hwang et al. (2012) also
followed-up with participants at three months post intervention.
Four studies combined cognitive training with physical exercise (Fiatarone Singh et al. 2014;
Kurz et al. 2009; Lam et al. 2015; Reuter et al. 2012). Three studies used interventions with
a combination of cognitive strategy training, psychoeducation, and social skills training
components (Joosten-Weyn Banningh et al. 2011; Joosten-Weyn Banningh et al. 2013;
Schmitter-Edgecombe and Dyck 2014). Two studies (Hwang et al. 2012; Law et al. 2014)
utilized interventions with computerized and non-computerized cognitive training
components. One study (Tsolaki et al. 2011) provided varying methods of non-computerized
cognitive training (e.g., paper-and-pencil tasks, prospective memory training, etc.). Reuter et
al. (2012) assigned groups to one of the following interventions: one group received
cognitive training, relaxation, and occupational therapy; one group with the previously stated
Author Manuscript
components plus a training skills application session; and one group with cognitive training,
application session, and additional motor skills training.
Meta-Analysis
Overall Effects—A subset of six of the 30 articles reviewed could not be used, in whole or
in part, in our meta-analysis due to failure to include sufficient information to compute
standardized mean differences; of these, four papers contributed no information to the meta-
analysis (Belleville et al. 2006; Fiatarone Singh et al. 2014; Finn and McDonald 2011;
Reuter et al. 2012), and two contributed only one or two outcomes because of a lack of
information about other outcomes in their paper (Hwang et al. 2012; Rojas et al. 2013).
Sample sizes included in the meta-analysis were smaller than the original, randomized
Author Manuscript
sample sizes described above due to attrition by the most distal follow-up occasion utilized
in the meta-analysis. Tables 2, 4, and 6 show the effect sizes for the studies included in the
meta-analysis along with the residual treated and control sample sizes employed in the meta-
analysis.
The mean effect size (d) representing the omnibus difference between improvement in the
treatment versus control group was 0.21 in the fixed effects model (95 % confidence interval
= 0.16–0.27, SE = 0.03), which was significantly different from zero (z = 7.50, p < .001,
based on 91 outcome measures), with the Q-statistic indicating significant heterogeneity in
effect size (χ2 [90] = 185.88, p < .001). In the random effects model, the mean effect size
representing the difference between improvement in the treatment versus control group was
0.26 (95 % confidence interval = 0.17–0.35, SE = 0.05), which was significantly different
Author Manuscript
from zero (z = 5.71, p < .001, based on the same 91 outcome measures). The Q-statistic, in
contrast, indicated homogeneity in effect size (χ2[90] = 78.54, p = .80). The tau estimate of
variance in population effect size was 0.08. Rejection of the null hypothesis of homogeneity,
at least in the fixed effect model, suggests that moderator models are indicated.
model indicated that this difference was significant (χ2 [2] = 8.56, p = .01). Table 7 displays
Author Manuscript
the number of outcomes (k), mean standardized effect size (d), 95 % confidence interval,
tau-squared (τ2), and p-value for the Q-test assessing the null hypothesis of homogeneity
within each therapy type as well as for each outcome category type. In all instances, the
random effects models could not reject the null hypothesis of homogeneity, meaning that
results were consistent within studies using similar intervention approaches. For all three
intervention types, treatment effects were positive (average d statistics ranged between 0.20
and 0.31, corresponding to a “small” effect size) and significantly different from zero.
outcomes. For mood, metacognition and ADLs, treatment effects were positive (average d
statistics ranged between 0.16 and 0.37, corresponding to a “small” or “small to medium”
effect size) and significantly different from zero. For QOL, average effect size was not
different from zero.
Mood: Four studies included a mood measure. Two of three studies employing the Geriatric
Depression Scale (GDS; Yesavage et al. 1983) reported improved scores on this instrument.
Two studies employing the State Trait Anxiety Inventory, State Scale (Spielberger 1983)
reported improved scores on this instrument. In one of those studies end of treatment
Author Manuscript
findings were negative but 12 month follow-up findings were positive. In a study also
employing the Neuropsychiatric Inventory (Cummings et al. 1994) an informant-based
measure of observed mood and behavior, NPI total was improved due to lower scores of
perceived depression, anxiety, and apathy. Finally, one additional study using an integrated
depression, anxiety, and stress scale (Depression, Anxiety and Stress Scale, DASS-21;
Lovibond and Lovibond 1995) found no impact of computer training in any of these three
domains.
QOL: Only one study (Gagnon and Belleville 2012) included a well-being scale. They
Author Manuscript
Summary: Computerized cognitive training in MCI did not appear to impact ADL measures
or measures of self-reported memory function. Evidence for an impact on mood was mixed,
with some studies reporting improvement in depression, anxiety, and perhaps apathy. There
was not enough research to comment on the impact of computerized training on QOL.
Author Manuscript
Mood: Mood was assessed in 12 studies, with only three studies reporting significant
change (Buschert et al. 2011; Konsztowicz et al. 2013; Lam et al. 2015). Kinsella et al.
(2009) actually found improved mood over time in their control group contrary to their
Author Manuscript
hypothesis. Buschert et al.’s report of mood improvement at training end was diminished by
15-month follow up (2012). There was little consistency in measures used, but four used the
MMQ Contentment Subscale. Similar to the ADL findings, only Konsztowicz et al. (2013)
reported improved contentment in their memory-training group.
QOL: QOL of assessed in six studies, with only two reporting significant improvement after
intervention (Vidovich et al. 2015; Belleville et al. 2006). The most commonly used measure
was the Quality of Life AD (Logsdon et al. 2002), used in three studies, only one of which
was significant (Vidovich et al. 2015).
Metacognitive: Participants’ sense of their memory or memory strategy use was assessed in
10 studies. Six studies had positive results (Belleville et al. 2006; Kinsella et al. 2009; Lam
Author Manuscript
et al. 2015; Rapp et al. 2002; Troyer et al. 2008; Vidovich et al. 2015). The MMQ Strategy
Use (self-reported memory strategy use) was the most often cited measure (4 out of the 10
studies).
Other: Greenaway et al. (2013) reported the impact of the intervention on caregivers, with
no effect on caregiver QOL or anxiety, but less sense of caregiver burden and depression
compared to the control group by six months post intervention. Buschert et al. (2012)
reported that 6 out of 12 of their CG had converted to dementia by eight months post, while
none of their IG had converted. Vidovich et al. (2015) found that 6.7 % of their CG and
Author Manuscript
11.9 % of their IG had converted to dementia at two years, but 45 % of their CG and 37 % of
their IG group had reverted to normal by two year follow-up.
Summary: The strongest evidence for everyday impact of therapist-based interventions was
for the improvement of metacognitive aspects of memory. After these cognitive
interventions, individuals with MCI believed they knew more strategies to help with their
memory and/or had more sense of self-efficacy surrounding their memory function.
Additionally, about half of studies demonstrated positive impact on ADLs, particularly when
practical compensation strategies were taught. This translated into little evidence for
improving mood or QOL in the participant with MCI, but there may be some positive
caregiver outcomes.
ADLs: Six of the 10 multimodal intervention studies assessed ADL outcomes, of which four
reported significant improvements. Two studies saw improvement on ADL rating scales with
cognitive plus physical interventions (Kurz et al. 2009; Lam et al. 2015) and one saw
positive impact with cognitive plus psychological interventions (Tsolaki et al. 2011).
Schmitter-Edgecombe and Dyck (2014), using cognitive plus psychological interventions,
found improvements on performance-based measures of ADLs involving bill-paying and
money management activities. Two studies utilizing the Bayer-ADL scale (B-ADL;
Hindmarch et al. 1998) saw inconsistent improvement. One study using both computerized
and non-computerized cognitive training (Law et al. 2014) provided follow-up analyses that
showed no sustained improvement in ADLs at 6-months follow-up.
Mood: Mood outcomes were mixed (assessed in 4/10 studies), with two cognitive plus
Author Manuscript
physical interventions (Kurz et al. 2009; Lam et al. 2015) showing improvement, and two
cognitive plus psychological interventions (Joosten-Weyn Banningh et al. 2011; Schmitter-
Edgecombe and Dyck 2014), showing no improvement upon intervention end. The two
studies that did not find improvements in mood used a short form version of the GDS
(Yesavage et al. 1983). No study assessed mood at a post-intervention follow-up.
QOL: QOL was assessed in four of the studies (Hwang et al. 2012; Joosten-Weyn Banningh
et al. 2011; Reuter et al. 2012; Schmitter-Edgecombe and Dyck 2014), and most of these
studies identified no impact. QOL improved in a cognitive plus psychological training
intervention (Joosten-Weyn Banningh et al. 2011) using the RAND-36-Dutch (Van der Zee
and Sanderman 1993). In this study, the Helplessness subscale of the Illness Cognition
Questionnaire (ICQ; Evers et al. 2001) was sensitive to change following the intervention;
Author Manuscript
however, the ICQ Acceptance subscale did not show improvement. The intervention group
from Reuter et al. (2012) received the most intensive treatment (i.e., cognitive and motor
training with practice) saw QOL improvements. No lasting impact on QOL was seen at 2-
week or 3-month follow-up intervals.
cognition scale at 2-week follow-up; however, these improvements were not sustained at
three months. Multi-modal interventions showed positive impact on self-reported and
informant based cognitive complaints (Lam et al. 2015; Joosten-Weyn Banningh et al. 2011)
but not in self-reported coping self-efficacy (Schmitter-Edgecombe and Dyck 2014).
Other: Two studies using cognitive plus psychological interventions analyzed the impact on
mood, QOL, and metacognition in caregivers (Schmitter-Edgecombe and Dyck 2014;
Joosten-Weyn Banningh et al. 2013). No improvements were found for mood, but one scale
of well-being indicated an improvement in QOL of caregivers (Joosten-Weyn Banningh et
al. 2013). Positive findings were found on scales of coping self-efficacy (Schmitter-
Edgecomb and Dyck 2014) and awareness of the MCI participant’s cognitive symptoms
(Joosten-Weyn Bannigh et al. 2013).
Author Manuscript
Summary: Although more studies found no impact on ADLs than benefit; the
improvements in ADLs were seen mostly in the cognitive plus physical interventions
studies. Mood improvements, particularly for depression, were mixed overall. But again, the
studies that found improvements in mood were cognitive plus physical interventions. There
was little evidence for impact of multimodal interventions on QOL. Metacognitive outcomes
were generally positive across multi-modal interventions. Preliminary evidence suggests
potential positive benefit in caregiver outcomes when cognitive plus psychotherapy
interventions are used. Overall, the most favorable outcomes tended to be in multimodal
studies that combined interventions with cognitive and physical training.
Publication Bias—For the overall corpus of studies, Rosenthal’s Fail Safe N was 2295,
indicating that there would need to be 2.295 unpublished studies not included in the meta-
Author Manuscript
analysis to make the population effect size non-significant. Begg and Mazumdar’s rank
correlation (tau) was .17 (p = .02) indicating small but non-trivial publication bias. Random-
effects weighted effect size estimates under the conditions of ‘moderate one-tailed
selection’, ‘severe one-tailed selection’, ‘moderate two-tailed selection’, and ‘severe two-
tailed selection’ were 0.15, −0.84, 0.21 and 0.16 respectively; this pattern of results suggests,
congruent with our confidence interval and stem-and-leaf information noted earlier, that the
overall average effect of 0.26 may be positively biased.
For the moderator analyses examining variation in effects by therapy modality and outcome
type, we have included the publication bias statistics in Table 7. In general, these findings
suggest that for the three different intervention types and four different outcome types, the
results are affected by mild publication bias.
Author Manuscript
Discussion
Cognitive interventions in MCI have received increased interest from the international
research community. Our review of the literature suggests that cognitive interventions in
MCI have the potential for positive impact, but as previous authors have suggested (Cooper
et al. 2013; Gates et al. 2011; Kurz et al. 2011), the heterogeneity of interventions and
outcome measures used make it difficult to determine the everyday impact.
By looking at trends across studies, we can speculate what the potential impact might be.
Author Manuscript
First, an overall meta-analysis combining all intervention and outcome types suggests that
cognitive interventions in MCI cohorts have a small, positive effect on everyday outcomes.
Therapist-based, computer-based, and multi-modal interventions all appear to have small but
significant effects on everyday outcomes. These effects are seen in mood, ADL and meta-
cognition measures but, at least for the studies included here, not in QOL outcomes. The
effect size estimates reported here were likely conservative, as we used the most distal
follow-up occasion available, which may have reduced the estimated effect sizes due to
treatment effect dissipation over time.
improvement in depression, anxiety, and perhaps apathy. There was little evidence for
improved mood from therapist-based cognitive training interventions.
When the intervention takes place with a therapist, either individually or in a group format,
positive impact on ADLs is more often observed. Computer based interventions did not
impact ADLs. The focus of therapist interventions is more often on compensation strategies
(either internally-based mnemonic strategies or externally-based aids such as calendars).
Perhaps this focus translates more readily to daily activity ability, as has been suggested
previously (Rodakowski et al. 2015). Therapist-based interventions also have promise for
improvement of metacognitive aspects of memory, such as how equipped a person feels with
regard to strategies to combat memory loss, and/or use memory strategies (i.e., memory self-
efficacy). There was little evidence of benefit to metacognitive variables from computerized
Author Manuscript
training.
Recently, studies of multimodal interventions have emerged into the literature. These
interventions seek to explore the benefits of cognitive interventions combined with other
promising nonpharmacological interventions like exercise and socialization/psychotherapy.
Many of these studies have employed therapist-based interventions, and the findings of
impact on ADLs, mood, and metacognitive variables largely mirror the single-modality
cognitive intervention literature. Combining physical and cognitive interventions appear to
be particularly beneficial.
There was an absence of QOL effects affects across cognitive interventions. This likely
reflects several factors. First, QOL is a complex construct with many inputs (e.g., health,
economic status, and social factors), so cognitive interventions might have only partial
Author Manuscript
effects. Secondarily, interventions have investment costs; they are effortful, demanding of
time, and may expose weaknesses that participants were not previously aware of prior to
being challenged by training exercises. All of these could be expected to have negative
impacts on reported QOL, particularly at the follow-up period immediately after treatment.
It should be noted that these studies employed cognitive interventions. It may be that the
inclusion of more direct “training for transfer” (i.e., including cognitive intervention
exercises that specifically address outcomes like ADL, mood, metacognition and QOL rather
Author Manuscript
than targeting cognition itself) may have further strengthen treatment generalization.
In this updated review, we sought to explore whether prior admonitions for this area of
research to employ larger trials, RCTs, and consistency in outcomes have been heeded.
Newer studies, particularly multimodal intervention studies, have used larger samples,
although the average number of individuals in each arm of trials still averages less than 30.
Only a few studies report sample sizes in the hundreds. Our review is encouraging that more
studies with larger samples are appearing. It is also encouraging that in these trials
recruitment rates (M = 58 %) and retention rates (M = 84 %) are compatible with what is
seen in other clinical trials such as pharmacological trials (Grill and Karlawish 2010) despite
the often significant time commitment.
When we set our inclusion and exclusion a priori for this review, we did not limit to RCTs,
Author Manuscript
but allowed CTs for inclusion. We actually found that a good number of recently conducted
trials were RCTs. The field appears to be progressing beyond small, uncontrolled feasibility
studies into larger RCTs. Because of this, future reviews can likely limit their analyses to
RCTs
Consistency in interventions and outcome variables remain key issues to overcome in this
literature. Most researchers appear to have created their own unique sets of cognitive
interventions and outcome measures. Many past studies were likely happening at the same
time, inspired by the few early works. Thus, unless they adopted outcome measures from
these first few studies (e.g., using the MMQ as Kinsella et al. 2009, and Troyer et al. 2008,
did in their early works), researchers were utilizing unique measures based on their own
experiences and research. Moreover, the locations where this research was conducted
Author Manuscript
(presented in Tables 1, 3, and 5) reflect just how international the research on cognitive
interventions for MCI truly has become. The global nature of this effort likely also
contributes to the variety of interventions and outcomes as multiple cultures and languages
seek to address cognitive rehabilitation in MCI.
The commonly used measures in this area of research can be found in Tables 2, 4, and 6. For
ADLs, we frequently saw the BADL (Hindmarch et al. 1998) used. The second most
commonly used measure of ADLs was the Clinical Dementia Rating Scale (CDR). The GDS
(Yesavage et al. 1983) was most often used in assessing mood, and more specifically,
depressive symptom outcomes. QOL was assessed most commonly with the Quality of Life-
Alzheimer’s disease (Logsdon et al. 2002). Metacognitive outcomes were most often
examined with the Memory Functioning Questionnaire (MMQ; Gilewski et al. 1990) or the
Metamemory Questionnaire (MMQ; Troyer and Rich 2002). The MMQ is one of the most
Author Manuscript
widely used instruments in general. This measure has subscales that examine ADLs (MMQ
Ability) and mood/QOL (MMQ contentment), so researchers often present all of these
aspects in their results. These instruments provide a good starting point to know what may
be useful in finding effect (e.g., the MMQ metacognitive scales), and those that perhaps may
be insensitive to finding change in the MCI population (e.g., the CDR may not sample
enough higher level ADLs). Other reviews further point out methodological steps that could
add consistency to cognitive intervention research in MCI (Hampstead et al. 2014; Huckans
Author Manuscript
et al. 2013).
Our systematic review and meta-analysis is limited by searching only MEDLINE and
PsychInfo databases. Thus, some studies may have been missed. We also excluded four non-
English studies due to our limited resources to translate them into English. Additionally, we
were unable to solicit missing information from 6 studies to complete effect sizes and
include them into the meta-analysis. Our findings may have been different had these
additional studies/variables been added.
Further, we allowed for the inclusion of both CTs and RCTs in this review. We found that
while most studies used a no-treatment control group, other studies, particularly the
computer-based interventions, at times used suspected active control interventions,
educational series, or even an alternative intervention suspected to not impact cognition in
Author Manuscript
the same way as the experimental intervention. The differentiation between what truly was
an active control and to what degree the education or alternative intervention would not
impact cognition or the everyday functioning variable regularly was not well established in
the articles, and was most often solely theoretically based. It is unclear if some impact of
these suspected “active control” interventions may have tempered the effect sizes of these
studies.
A key question in meta-analysis is the issue of publication bias. That is, to what extent might
publication bias lead to an inflated or distorted estimate of true effect sizes? Concerns about
publication bias likely hold for this corpus of thirty studies: (A) We did not solicit
unpublished papers from outside the search databases listed; (B) We did not consult clinical
trials registries to identify additional registered trials that have not been published; and (C)
Author Manuscript
Published papers will be biased towards those with significant findings (Coursol and Wagner
1986; Greenwald 1975). However, it is noteworthy that most of the reviewed studies had a
primary aim of having cognitive effects. Thus, most the outcomes considered in this review
were in fact secondary, transfer outcomes for these studies. Often these everyday impact
measures were given only a brief mention in the final paragraph of the results or embedded
in a table without further explanation. This incidental reporting of positive or negative
secondary results may have mitigated publication bias effects to some degree in this meta-
analysis of everyday outcomes.
Indeed, our quantitative explorations of publication bias suggested the presence of relatively
minor positive bias. For the overall set of studies, and for the subgroups of therapy
modalities and outcomes, results suggested that anywhere from three to fifteen times the
number of included studies would have to have been left out for significant d statistics to
Author Manuscript
become non-significant. Rank correlation tested indicated generally only small associations
between d and its standard error, suggestive of at most mild bias. Taken together, while
publication bias undoubtedly influences the average effect sizes reported here, we have
reason to believe that the median effect sizes and 95 % confidence intervals (all but one of
which excludes d = 0.00) likely include the true population effect size.
Substantial research is still needed to determine the basic “active ingredients” of cognitive
Author Manuscript
training and behavioral interventions in MCI, including the specific and non-specific
treatment effects, dosing (i.e., number of sessions over what time frame), best training
context (e.g., group vs. individual), participant variables affecting specific outcomes, etc.
Further, research into how combining multiple nonpharmacological interventions may have
synergistic impacts on everyday outcomes will perhaps produce the most effective
“treatment sets” for MCI. Ideally, one day it will be possible to tailor treatment plans, using
evidence-based interventions, to the outcomes that patients define as most important to
them. Until then, much more investigation is needed to determine the impact of cognitive
interventions on everyday outcomes in MCI, as, to date, only modest overall effect sizes
were found in this meta-analysis.
Acknowledgments
Author Manuscript
Funding
Research reported in this manuscript was partially funded through a Patient-Centered Outcomes Research Institute
(PCORI) Award (CER-1306-01,897). The statements in this publication are solely the responsibility of the authors
and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board
of Governors or Methodology Committee.
References
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild
cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on
Aging-Alzheimer’s association workgroups on diagnostic guidelines for Alzheimer’s disease.
Alzheimers Dement. 2011; 7(3):270–279. DOI: 10.1016/j.jalz.2011.03.008 [PubMed: 21514249]
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5.
Washington, DC: Author; 2013.
Author Manuscript
Barrios PG, Pabon RG, Hanna SM, Lunde AM, Fields JA, Locke DEC, Smith GE. Priority of
treatment outcomes for caregivers and patients with mild cognitive impairment: preliminary
analyses. Neurology and Therapy. 2016; :1–10. DOI: 10.1007/s40120-016-0049-1 [PubMed:
26894299]
Baum, C.; Morrison, T.; Hahn, M.; Edwards, D. Program in Occupational Therapy. Washington
University School of Medicine; St. Louis: 2007. Executive Function Performance Test.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias.
Biometrics. 1994; 50(4):1088–1101. DOI: 10.2307/2533446 [PubMed: 7786990]
Belleville S. Cognitive training for persons with mild cognitive impairment. International
Psychogeriatrics. 2008; 20(1):57–66. [PubMed: 17958927]
Belleville S, Gilbert B, Fontaine F, Gagnon L, Menard E, Gauthier S. Improvement of episodic
memory in persons with mild cognitive impairment and healthy older adults: evidence from a
cognitive intervention program. Dementia & Geriatric Cognitive Disorders. 2006; 22(5–6):486–499.
[PubMed: 17050952]
Bravo G, Gaulin P, Dubois MF. Validation d’une échelle de bien-être général auprès d’une population
Author Manuscript
disease: a pilot study. Journal of Alzheimer’s Disease. 2011; 25(4):679–694. DOI: 10.3233/
JAD-2011-100999
Author Manuscript
Buschert VC, Giegling I, Teipel SJ, Jolk S, Hampel H, Rujescu D, et al. Long-term observation of a
multicomponent cognitive intervention in mild cognitive impairment. Journal of Clinical
Psychiatry. 2012; 73(12):e1492–e1498. DOI: 10.4088/JCP.11m07270 [PubMed: 23290333]
Cheong L, Lam W, Chiu L, Chiu K, Fung H. Validation of a memory inventory for the assessment of
awareness of memory deficits in Alzheimer’s disease in Chinese elderly. International Journal of
Geriatric Psychiatry. 2006; 21(10):917–923. [PubMed: 16927409]
Chesney MA, Neilands TB, Chambers DB, Taylor JM, Folkman S. A validity and reliability study of
the coping self-efficacy scale. British Journal of Health Psychology. 2006; 11(3):421–437.
[PubMed: 16870053]
Clare L, Woods RT, Moniz Cook ED, Orrell M, Spector A. Cognitive rehabilitation and cognitive
training for early-stage Alzheimer’s disease and vascular dementia. The Cochrane Database of
Systematic Reviews. 2003; 4doi: 10.1002/14651858.CD003260
Cooper C, Li R, Lyketsos C, Livingston G. Treatment for mild cognitive impairment: systematic
review. British Journal of Psychiatry. 2013; 203(3):255–264. DOI: 10.1192/bjp.bp.113.127811
Author Manuscript
[PubMed: 24085737]
Coursol A, Wagner EE. Effect of positive findings on submission and acceptance rates: A note on
meta-analysis bias. Professional Psychology. 1986; 17:136–137. DOI:
10.1037/0735-7028.17.2.136
Coyle H, Traynor V, Solowij N. Computerized and virtual reality cognitive training for individuals at
high risk of cognitive decline: systematic review of the literature. American Journal of Geriatric
Psychiatry. 2015; 23(4):335–359. DOI: 10.1016/j.jagp.2014.04.009 [PubMed: 24998488]
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The
neuropsychiatric inventory comprehensive assessment of psychopathology in dementia.
Neurology. 1994; 44(12):2308–2308. [PubMed: 7991117]
De Jonghe J, Schmand B, Ooms M, Ribbe M. Abbreviated form of the informant questionnaire on
cognitive decline in the elderly. Tijdschrift voor Gerontologie en Geriatrie. 1997; 28(5):224–229.
[PubMed: 9526793]
Evers AW, Kraaimaat FW, van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable
thinking: the illness cognition questionnaire for chronic diseases. Journal of Consulting and
Author Manuscript
impairment: a pilot study using a randomised controlled trial design. Brain Impairment. 2011;
12(3):187–199. DOI: 10.1375/brim.12.3.187
Finn M, McDonald S. Repetition-lag training to improve recollection memory in older people with
amnestic mild cognitive impairment. A randomized controlled trial. Aging, Neuropsychology, and
Cognition. 2015; 22(2):244–258. DOI: 10.1080/13825585.2014.915918
Fundaciò Privada Espai Salut. Feskits estimulación cognitiva. Barcelona, Spain: 2009. Version
2.5Available at http:/www.feskits.com
Gagnon LG, Belleville S. Training of attentional control in mild cognitive impairment with executive
deficits: results from a double-blind randomised controlled study. Neuropsychological
Author Manuscript
[PubMed: 21942932]
Giebel C, Challis D. Translating cognitive and everyday activity deficits into cognitive interventions in
mild dementia and mild cognitive impairment. International Journal of Geriatric Psychiatry. 2015;
30(1):21–31. DOI: 10.1002/gps.4170 [PubMed: 24990546]
Gilewski MJ, Zelinski EM, Schaie KW. The Memory Functioning Questionnaire for assessment of
memory complaints in adulthood and old age. Psychology and aging. 1990; 5(4):482–490.
[PubMed: 2278670]
Greenaway MC, Duncan NL, Smith GE. The memory support system for mild cognitive impairment:
randomized trial of a cognitive rehabilitation intervention. International Journal of Geriatric
Psychiatry. 2013; 28(4):402–409. DOI: 10.1002/gps.3838 [PubMed: 22678947]
Greenwald AG. Consequences of prejudice against null hypothesis. Psychological Bulletin. 1975;
82(1):1–19. DOI: 10.1037/h0076157
Grill JD, Karlawish J. Addressing the challenges to successful recruitment and retention in
Alzheimer’s disease clinical trials. Alzheimer’s Research & Therapy. 2010; 2(6):34.doi: 10.1186/
alzrt58
Author Manuscript
Hampstead BM, Gillis MM, Stringer AY. Cognitive rehabilitation of memory for mild cognitive
impairment: a methodological review and model for future research. Journal of the International
Neuropsychological Society. 2014; 20(2):135–151. DOI: 10.1017/S1355617713001306 [PubMed:
24331156]
Hautzinger, M.; Bailer, M.; Worall, H.; Keller, F. Beck depression inventory (BDI). Bern: Huber; 1994.
Hedges, L.; Olkin, I. Statistical methods for meta-analysis. New York: Academic Press; 1985.
Herrmann N, Mittmann N, Silver IL, Shulman KI, Busto UA, Shear NH, et al. A validation study of
the geriatric depression scale short form. International Journal of Geriatric Psychiatry. 1996; 11(5):
457–460.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;
21(11):1539–1558. DOI: 10.1002/sim.1186 [PubMed: 12111919]
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ.
2003; 327(7414):557–560. DOI: 10.1136/bmj.327.7414.557 [PubMed: 12958120]
Hindmarch I, Lehfeld H, de Jongh P, Erzigkeit H. The Bayer Activities of Daily Living scale (B-ADL).
Author Manuscript
Dementia and Geriatric Cognitive Disorders. 1998; 9(Suppl 2):20–26. [PubMed: 9718231]
Huckans M, Hutson L, Twamley E, Jak A, Kaye J, Storzbach D. Efficacy of cognitive rehabilitation
therapies for mild cognitive impairment (MCI) in older adults: working toward a theoretical model
and evidence-based interventions. Neuropsychology Review. 2013; 23(1):63–80. DOI: 10.1007/
s11065-013-9230-9 [PubMed: 23471631]
Hughes TF, Flatt JD, Fu B, Butters MA, Chang CC, Ganguli M. Interactive video gaming compared
with health education in older adults with mild cognitive impairment: a feasibility study.
International Journal of Geriatric Psychiatry. 2014; 29(9):890–898. DOI: 10.1002/gps.4075
[PubMed: 24452845]
Hutton, JT. Alzheimer’s disease. In: Rakel, RE., editor. Conn’s Current Therapy. Philadelphia: W. B.
Saunders; 1990. p. 778-781.
Author Manuscript
Hwang HR, Choi SH, Yoon DH, Yoon BN, Suh YJ, Lee D, et al. The effect of cognitive training in
patients with mild cognitive impairment and early Alzheimer’s disease: a preliminary study.
Journal of Clinical Neurology. 2012; 8(3):190–197. DOI: 10.3988/jcn.2012.8.3.190 [PubMed:
23091528]
Jamrozik K, Norman PE, Spencer CA, Parsons RW, Tuohy R, Lawrence-Brown MM, et al. Screening
for abdominal aortic aneurysm: lessons from a population-based study. The Medical Journal of
Australia. 2000; 173(7):345–350. [PubMed: 11062788]
Jean L, Bergeron ME, Thivierge S, Simard M. Cognitive intervention programs for individuals with
mild cognitive impairment: systematic review of the literature. American Journal of Geriatric
Psychiatry. 2010a; 18(4):281–296. DOI: 10.1097/JGP.0b013e3181c37ce9 [PubMed: 20220584]
Jean L, Simard M, Wiederkehr S, Bergeron ME, Turgeon Y, Hudon C, et al. Efficacy of a cognitive
training programme for mild cognitive impairment: results of a randomised controlled study.
Neuropsychological Rehabilitation. 2010b; 20(3):377–405. DOI: 10.1080/09602010903343012
[PubMed: 20029715]
Author Manuscript
cognition?: a cluster randomized controlled trial. PLoS ONE. 2015; 10(3):e0118173.doi: 10.1371/
journal.pone.0118173 [PubMed: 25826620]
Author Manuscript
19808842]
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and
meta-analyses: the PRISMA statement. PLoS Medicine. 2009; 6(7):e1000097.doi: 10.1371/
journal.pmed1000097 [PubMed: 19621072]
Mok C, Siu A, Chan W, Yeung K, Pan P, Li S. Functional disabilities profile of Chinese version of the
Disability Assessment for Dementia (CDAD). Dementia and Geriatric Cognitive Disorders. 2005;
20:112–119. [PubMed: 15990425]
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The British
Journal of Psychiatry. 1979; 134(4):382–389. [PubMed: 444788]
Morris JC. The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology. 1993;
43(11):2412–2412. [PubMed: 8232972]
Nakatsuka M, Nakamura K, Hamanosono R, Takahashi Y, Kasai M, Sato Y, et al. A cluster
randomized controlled trial of nonpharmacological interventions for old-old subjects with a
clinical dementia rating of 0.5: the Kurihara project. Dementia and Geriatric Cognitive Disorders
Extra. 2015; 5(2):221–232. DOI: 10.1159/000380816 [PubMed: 26195978]
Author Manuscript
Overton RC. A comparison of fixed-effects and mixed (random-effects) models for meta-analysis tests
of moderator variable effects. Psychological Methods. 1998; 3(3):354–379. DOI:
10.1037/1082-989X.3.3.354
Patterson TL, Lacro J, McKibbin CL, Moscona S, Hughs T, Jeste DV. Medication management ability
assessment: results from a performance-based measure in older outpatients with schizophrenia.
Journal of Clinical Psychopharmacology. 2002; 22(1):11–19. [PubMed: 11799337]
Petersen RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine. 2004;
256(3):183–194. [PubMed: 15324362]
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment:
clinical characterization and outcome. Archives of Neurology. 1999; 56(3):303–308. [PubMed:
Author Manuscript
10190820]
Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Jack CR. Mild cognitive
impairment: ten years later. Archives of Neurology. 2009; 66(12):1447–1455. [PubMed:
20008648]
Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P. MCI Working Group of the European
Consortium on Alzheimer’s Disease. Mild cognitive impairment (MCI) in medical practice: A
critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of
the European Consortium on Alzheimer’s Disease. Journal of Neurology, Neurosurgery &
Psychiatry. 2006; 77(6):714–718.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population.
Applied Psychological Measurement. 1977; 1:385–401.
Rapp S, Brenes G, Marsh AP. Memory enhancement training for older adults with mild cognitive
impairment: a preliminary study. Aging & Mental Health. 2002; 6(1):5–11. [PubMed: 11827617]
Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people
Author Manuscript
with mild cognitive impairment: a systematic review. Ageing Research Reviews. 2013; 12(1):263–
275. DOI: 10.1016/j.arr.2012.07.003 [PubMed: 22841936]
Reuter I, Mehnert S, Sammer G, Oechsner M, Engelhardt M. Efficacy of a multimodal cognitive
rehabilitation including psychomotor and endurance training in Parkinson’s disease. Journal of
Aging Research. 2012; :1.doi: 10.1155/2012/235765
Rodakowski J, Saghafi E, Butters MA, Skidmore ER. Non-pharmacological interventions for adults
with mild cognitive impairment and early stage dementia: an updated scoping review. Molecular
Aspects of Medicine. 2015; 43–44:38–53. DOI: 10.1016/j.mam.2015.06.003
Rojas GJ, Villar V, Iturry M, Harris P, Serrano CM, Herrera JA, et al. Efficacy of a cognitive
intervention program in patients with mild cognitive impairment. International Psychogeriatrics.
2013; 25(5):825–831. DOI: 10.1017/S1041610213000045 [PubMed: 23414646]
Rosenthal R. The file drawer problem and tolerance for null results. Psychological Bulletin. 1979;
86(3):638–641. DOI: 10.1037/0033-2909.86.3.638
Rozzini L, Costardi D, Chilovi BV, Franzoni S, Trabucchi M, Padovani A. Efficacy of cognitive
rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Author Manuscript
Simon SS, Yokomizo JE, Bottino CM. Cognitive intervention in amnestic mild cognitive impairment: a
systematic review. Neuroscience & Biobehavioral Reviews. 2012; 36(4):1163–1178. DOI:
10.1016/j.neubiorev.2012.01.007 [PubMed: 22322184]
Sinforiani E, Banchieri L, Zucchella C, Pacchetti C, Sandrini G. Cognitive rehabilitation in
Parkinson’s disease. Archives of Gerontology and Geriatrics. 2004; 38:387–391. [PubMed:
15207437]
Smith G, Petersen R, Parisi J, Ivnik R, Kokmen E, Tangalos E, et al. Definition, course and outcome of
mild cognitive impairment. Aging, Neuropsychology, and Cognition. 1996; 3:141–147.
Spielberger, CDG.; RL; Lushene, R.; Vagg, PR.; Jacobs, GA. Manual for the State-Trait Anxiety
Inventory. Palo Alto: Consulting Psychologists Press; 1983.
Author Manuscript
Spina, L.; Ruff, R.; Mahncke, H. Cognitive Self-Report Questionnaire (CSRQ) Manual. San Francisco:
Posit Science Corporation; 2006.
Stott J, Spector A. A review of the effectiveness of memory interventions in mild cognitive impairment
(MCI). International Psychogeriatrics. 2011; 23(4):526–538. DOI: 10.1017/S1041610210001973
[PubMed: 20946704]
Sunderland A, Harris JE, Gleave J. Memory failures in everyday life following severe head injury.
Journal of Clinical Neuropsychology. 1984; 6(2):127–142. [PubMed: 6736263]
Talassi E, Guerreschi M, Feriani M, Fedi V, Bianchetti A, Trabucchi M. Effectiveness of a cognitive
rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case
control study. Archives of Gerontology & Geriatrics. 2007; 44(Suppl 1):391–399. [PubMed:
17317481]
Tong AY, Man DW. The validation of the Hong Kong Chinese version of the Lawton instrumental
activities of daily living scale for institutionalized elderly persons. Occupational Therapy Journal
of Research: Occupation, Participation and Health. 2002; 22(4):132.
Author Manuscript
Troyer AK, Rich JB. Psychometric properties of a new metamemory questionnaire for older adults.
The Journals of Gerontology Series B, Psychological Sciences and Social Sciences. 2002;
57(1):P19–P27.
Troyer AK, Murphy KJ, Anderson ND, Moscovitch M, Craik FI. Changing everyday memory
behaviour in amnestic mild cognitive impairment: a randomised controlled trial.
Neuropsychological Rehabilitation. 2008; 18(1):65–88. [PubMed: 17943615]
Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, et al. Effectiveness of
nonpharmacological approaches in patients with mild cognitive impairment. Neurodegenerative
Diseases. 2011; 8(3):138–145. DOI: 10.1159/000320575 [PubMed: 21135531]
Tun PA, Wingfield A. Does dividing attention become harder with age? Findings from the Divided
Attention Questionnaire. Aging, Neuropsychology, and Cognition. 1995; 2(1):39–66.
Van der Linden, M.; Wyns, C.; Coyette, F.; von Frenckell, R.; Seron, X. Questionnaire d’auto-
évaluation de la mémoire. Editest; Bruxelles, Belgique: 1989.
Van der Zee, K.; Sanderman, R. RAND-36. Groningen: Northern Centre for Health Care Research,
Author Manuscript
Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation
of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research.
Author Manuscript
Appendix
AD))).tw
3. 1 AND 2
5. 3 NOT 4
7. 5 NOT 6
neoplas* or epilep*)).tw.
10. 8 AND 9
3. 1 AND 2
Author Manuscript
6. 4 NOT 5
Author Manuscript
Fig. 1.
Cumulative growth of controlled trials of cognitive interventions in MCI over time. To fully
illustrate the total number of studies in this area, studies that included no generalization
outcome measure (i.e., controlled trials of cognitive interventions in MCI that only provided
Author Manuscript
cognitive measures or fMRI outcomes) that were excluded from the general review are
shown in this figure as “Non-gen outcome”
Author Manuscript
Author Manuscript
Fig. 2.
PRISMA Flow Diagram. Flow diagram illustrating the process of inclusion/exclusion of
studies
Author Manuscript
Author Manuscript
Table 1
MCIa (n MCIa
(2014); Australia = 24) Sham cognitive Approached 2,094 research program: adaptive week for 6 months or (intervention
activity and participants, 1994 Not exercises of memory, EF, 52–78 sessions end)
exercise ineligible (1582 not attention, and processing 60–100 minutes 18 months (12
control interested, 217 on hold, 117 speed, and sham months post
condition (n = ineligible, 61 no contact, 17 physical training intervention)
27) withdrawals), 100 enrolled
Attrition: 14 dropped out
before intervention, 12
dropped out after
intervention
Finn & McDonald RCT aMCIb aMCIb single Recruitment: 27 people Lumosity program 30 sessions, for 6 Intervention end Improved visual sustained
(2011); Australia single and multiple recruited from memory weeks attention, no treatment effect
and domains clinic 2 excluded prior to on visual learning,
multiple Waitlist (n = 8) randomization, 12 recognition, working
domains randomized to intervention, memory or set shifting
(n = 8) (3 withdrawals in IG, 1
additional exclusion), 13 to
control, (4 withdrawals 1
additional exclusion)
Attrition: None
Gagnon & Belleville RCT MCIa (n MCIa Recruitment: Approached 79 Variable priority 6 sessions 1 hour Intervention end Both groups improved on
(2012); Canada = 12) Active candidates from memory attention training sessions spread of 2 focused attention, speed of
computer disorders clinics, 53 weeks processing, and switching
training (n = excluded, 26 randomized, 13
12) randomized to each group
Attrition: 2 did not complete
Gaitan et al. (2013); RCT aMCIa aMCIa single Recruitment: 60 candidates Group-based FesKits 30 sessions 30- 3 months No significant improvement
Spain single and multiple randomly selected from pool computer program minute computer 12 months
and domains. of 93 interested, 37 sessions embedded in
multiple Traditional randomized to intervention 1-hour traditional
domains cognitive (6 refused or did no cognitive therapy
(n = 23) training (n = complete baseline), 23 to session
(n = 22)
Talassi et al. (2007); CT MCIa (n MCIa Recruited from a day TNP computer program, 12 sessions Intervention end No significant improvement
Italy = 30) Non-cognitive rehabilitation hospital occupational therapy of 4 days per week for 3
activities ADLs, and behavioral weeks
(physical therapy
therapy,
occupational
therapy, and
behavioral
therapy) (n =
7)
AChEI = Acetylcholinesterase inhibitor. aMCI = Mild cognitive impairment, amnestic subtype. CG = control group. CT = Controlled trial. f/u = Follow-up. IG = Intervention group. MCI = Mild cognitive
impairment. RCT = Randomized controlled trial.
§
Within-subjects change.
Interventions: COGPACK® (Marker 2008). FesKits (Fundacio Privada Espai Salut 2009). Nintendo Wii™ (Nintendo of America Inc., Redmond, WA). TNP (Sinforiani et al. 2004).
Table 2
Note. Measures are provided with + or − to reflect whether the outcome was significant. When it was possible to calculate effect size, those numbers are provided next to the relevant test (effect size, final
number of participants treated by that time point, final number of comparison participants by that time point). Positive effect sizes reflect greater improvement for treatment group relative to comparison
Measures: BADL (Bayer-Activities of Daily Living; Hindmarch et al. 1998); CSRQ (Cognitive Self-report Questionnaire; Spina et al. 2006); DASS-21 (Depression Anxiety Stress Scale; Lovibond and
Lovibond 1995); DAQ (Divided Attention Questionnaire; Tun and Wingfield 1995); GDS (Geriatric Depression Scale; Yesavage et al. 1983); IADL (Instrumental Activities of Daily Living; Lawton and
Brody 1969); MCI (Memory Controllability Inventory; Lachman et al. 1995); MFEM (Memory Failures in Everyday Memory; Sunderland et al. 1984); MFQ: (Memory Functioning Questionaire; Gilewski
et al. 1990); NPI (Neuropsychiatric Inventory; Cummings et al. 1994); STAI (State Trait Anxiety Inventory; Spielberger 1983); WBS (Well-Being Scale; Bravo et al. 1996).
Page 30
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Table 3
Argentina completed Waitlist (n = met MCI criteria, 21 not Cognitive sessions per week for cognition, memory
through 12 15) interested in study, 46 Intervention 6 months recognition, and
month f/u randomized Program vs. semantic fluency.
Attrition: 9 left trained group, combination of Improvement in IG in
7 left control group (4 cognitive naming and semantic
converted to dementia, 8 stimulation fluency
“family reasons” 2 medical (socializing),
reasons/death, 2 not cognitive exercises,
interested) cognitive training in
mnemonics, general
information on MCI
and external aids
Troyer et al. (2008); RCT aMCIa (n = 23) aMCIa Recruitment: 68 eligible, 5 Group-based 10 sessions 3 months No impact on objective
Canada Waitlist (n = declined, 9 used in pilot. 54 Combination of 2 hour group sessions memory tasks of face-
22) randomized information, for 6 months name learning, number
Attrition: 3 withdrew before intervention training learning, or wordlist
intervention, 3 did not (both external and learning
complete, 3 withdrew before mnemonic) and
3 month f/u homework practice
Vidovich et al. RCT MCIe MCIe Recruitment: 324 assessed Group-based 10 sessions 10 weeks IG had significantly
(2015); Australia 10 weeks (n = Education (114 ineligible; 50 refused), Cognitive activity 90 minute sessions 1 year better digits forward
77) 10 weeks (n = 160 randomized training strategy for 5 weeks 2 years compared to CG after 2
1 year (n = 77) 79) Attrition: 20 CG lost to f/u with cognitive years, but actual amount
2 year (n = 67) 1 year (n = 77) (13 declined, 3 died, 4 ill); 13 rehab, stimulation, of difference so small of
2 year (n = 60) IG lost to f/u (10 declined, 1 and training uncertain significance
died, 2 ill) elements versus
education group
control
aMCI = Mild cognitive impairment, amnestic subtype. CG = Control group. CT = Controlled trial. f/u = Follow-up. IG = Intervention group. MCI = Mild cognitive impairment. RCT = Randomized
controlled trial.
Page 33
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Table 4
Wellbeing*/+
(2006) Personal events/+
Places, Political, social events/+
Conversations/−
Books and movies/−
Slip of attention/−
People/−
Use of objects/−
Actions of perform/−General/−
Buschert et al. MADRS QOL-AD 6/12 in CG (who were
(2011) & (2012) Intervention end/+ Intervention end/− given intervention
15 months f/u/− 15 months f/u/− after 8 months)
24 months f/u/− 24 months f/u/− converted to dementia.
(d = 0.64, 10, 12) (d = 0.51, 10, 12) None in the first IG
converted
Brum et al. (2009) DAFS-R Subtests GDS/−
Orientation/+ (d = 0.53, 16, 18)
(d = 0.93, 16, 18)
Communication/−
(d = 0.07, 16, 18)
Finances/+
(d = 1.30, 16, 18)
Shopping/−
(d = 0.49, 16, 18)
Total/+
(d = 1.30, 16, 18)
Finn and DASS-21 Subtests CFQ/−
McDonald (2015) Depression/− (d = 0.29, 12, 12)
(d = −0.24, 12, 12)
Anxiety/−
(d = −0.26, 12, 12)
Stress/−
(d = −0.32,12,12)
4 weeks f/u / −
(d = 0.27, 11, 9)
Kinsella et al. MMQ Ability subscale MMQ contentment MMQ Strategy Use
(2009) 2 weeks f/u / − 2 weeks f/u /− 2 weeks f/u /+
4 month f/u / − 4 month f/u /+ 4 month f/u /+
(d = −0.07, 22, 22) improved waitlist (opposite of (d = 0.14, 22, 22)
hypothesized) Strategy Knowledge*
(d = −0.13, 22, 22) 2 weeks f/u /+
4 month f/u /+
(d = 0.24, 15, 16)
Konsztowicz et al. MMQ Ability** MMQ Contentment** MMQ Strategy Use**
(2013) Memory Trained/+ Memory Trained/+ Memory Trained/−
(d = 0.36, 8, 4) (d = 0.94, 8, 4) (d = 1.07, 8, 4)
Memory Compensation/− Memory Compensation/− Memory Compensation/−
(d = −0.04, 7, 4) (d = 0.30, 7, 4) (d = 0.54, 7, 4)
Lam et al. (2015) CDAD/− CSDD/+ MIC/+
(d = 0.13, 115, 101) (d = −0.05, 115, 101) (d = 0.09, 115, 101)
CDR/−
(d = 0.15, 115, 101)
Nakatsuka et al. GDS-SF/− Quality of Life Face
(2015) (d = −0.08, 32, 39) scale*/−
(d = −0.39, 32, 39)
Rapp et al. (2002) MCI Present Ability* MFQ General Functioning
Intervention end/+ Intervention end/−
6 months f/u/ + 6 months f/u/−
(d = 0.69, 7, 9) (d = 0.26, 7, 9)
MFQ Frequency of Forgetting MFQ Seriousness
Intervention end/− Intervention end/−
6 months f/u/ − 6 months f/u/−
(d = −0.09, 7, 9) (d = 0.12, 7, 9)
Troyer et al. (2008) MMQ Ability** MMQ Contentment** Memory strategy knowledge*,**
Intervention end/− Intervention end/− Intervention end/+
3 months f/u/− 3 months f/u/− 3 months f/u/+
(d = 0.81, 23, 22) (d = −0.03, 23, 22) (d = 0.31, 23, 22)
Self-report strategy use during testing*
Intervention end/+
3 months f/u/−
(d = 1.21, 23, 22)
MMQ Strategy Use
Intervention end/+
3 months f/u/+
(d = 0.74, 23, 22)
Vidovich et al. SAILS**/− PHQ-9**/− QOL-AD**/+ MFQ Mnemonics Use**/+ LAQ/−
(2015) (d = −0.14, 66, 60) (d = 0.05, 67, 60) (d = 0.23, 67, 60) IG reported significantly lower use of mnemonics in PAQ/−
daily life (opposite of hypothesized) SNSQ/−
(d = −0.18, 67, 59) 27/60 CG no longer
MCI (reverted) at 2
MFQ General Forgetting**/− years
(d = −0.12, 66, 58) 25/67 IG no longer
MFQ Seriousness of Forgetting/− MCI
MFQ Retrospective Functioning**/− 6 CG and 10 IG
(d = 0.45, 67, 59) converted to dementia
at 2 years
Note. Measures are provided with + or − to reflect whether it was reported as significantly different in the study. When it was possible to calculate effect size, those numbers are provided next to the relevant
test (effect size, final number of participants treated by that time point, final number of comparison participants by that time point, positive effect sizes reflect greater improvement for treatment group
relative to comparison group). Cohen’s d effect size computed as [(posttesttreatment − pretesttreatment) − (posttestcontrol − pretestcontrol)]/(pooled baseline standard deviation of both groups). Outcomes
without an effect size did not provide information necessary to compute standardized mean differences. CG = Control group. f/u = Follow-up. IG = Intervention group.
*
Study-specific measure.
Measures: ADLS (Activity of Daily Living Scale; Lawton and Brody 1969); CB (Caregiver Burden; Zarit 1990); CDAD (Chinese Disability Assessment for Dementia; Mok et al. 2005); CDR (Clinical
Dementia Rating; Morris 1997); CES-D (Centers for Epidemiological Studies -Depression; Radloff 1977); CFQ (Cognitive Failures Questionnaire; Broadbent et al. 1982); CSDD (Cornell Scale for
Depression in Dementia; C. Lam et al. 2004); DAFS-R (Direct Assessment of Functional Status; Loewenstein and Bates 1989); DASS-21 (Depression Anxiety Stress Scale; Lovibond and Lovibond 1995);
E-Cog (Everyday Cognition Memory Subtest; Farias et al. 2008); GDS-SF (Geriatric Depression Scale-Short form; Sheikh et al. 1986); LAQ (Leisure Activity Questionnaire; Verghese et al. 2003);
MADRS (Montgomery-Asberg Depression Scale; Montgomery and Asberg 1979); MIC (Memory Inventory for Chinese; Cheong et al. 2006); MFQ (Memory Functioning Questionnaire; Gilewski et al.
1990); MMQ (Multifactorial Metamemory Questionnaire;Troyer and Rich 2002); NPI (Neuropsychiatric Inventory; Cummings et al. 1994); QAM (Questionnaire d’auto-evaluation de la memoire; Van der
Linden et al. 1989); PAQ (Physical Activity Questionnaire; Jamrozik et al. 2000); PHQ-9 (Patient Health Questionnaire-Nine Item; Kroenke et al. 2001); QOL-AD (Quality of Life-Alzheimer’s Disease;
Logsdon et al. 2002); QOLQ (Quality of Life Questionnaire; Machnicki et al. 2009); RBMT (Rivermead Behavioral Memory Test; Wilson et al. 1989); REACH (Resources for Enhancing Alzheimer’s
Caregiver’s Health; Wisniewski et al. 2003); SAILS (Structured Assessment of Independent Living Skills; Mahurin et al. 1991); SNSQ (Social Network Satisfaction Questionnaire; Koenig et al. 1993).
Page 36
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
Table 5
MCIa MCIa
(2014); Australia Cognitive Sham research participants COGPACK® adaptive 2–3 sessions per (intervention improved at f/u
training and cognitive approached, 1994 not computerized week, for 6 months end)
physical activity and eligible (1582, not exercises of memory, 18 month (12
resistance exercise (n = interested, 214 on hold, executive function, months post
training (n = 27) 117 ineligible, 61 no attention, and intervention)
27) contact, 17 withdrawn); processing speed
100 enrolled Physical resistance
Attrition: 14 did not training: High
complete, 12 dropped out intensity pneumatic
at f/u resistance machines
targeting most major
muscle groups
Hwang et al. (2012); RCT aMCIa (n = aMCIa waitlist Recruitment: Consecutive Cognitive training: 18 weekly sessions, 2 weeks Verbal memory significantly
South Korea 6) (n = 5) memory clinic outpatients Individualized, 50-minutes each 3 months improved at f/u, other cognitive
(no details given) multicomponent session domains trending towards
Attrition: 2 withdrew program (reality improvement at follow-up
orientation,
computerized
attentional training,
memory training,
visuo-construction
training, executive
function training,
abstract thinking,
homework)
Joosten-Weyn CT MCIa (n = MCIa waitlist Recruitment: 93 enrolled Group-based therapy: 10 weekly sessions, 2 6–8 months
Banningh et al. 47) (n = 40) Attrition: 6 withdrew cognitive behavioral hours each session
(2011); Netherlands therapy principles
with psychoeducation
and memory
rehabilitation, coping
skills
23) Standard care: Attrition: 2 dyads did not psychoeducation and problem solving”
“routine complete, 2 dyads workshop, and sessions, 20 sessions
physician withdrew after “strategy training and total, 2 sessions per
visits, intervention completion problem solving” week for 10 weeks, 2
monitoring of but before post-testing group sessions hours per session
disease involving
progression, communication and
active lifestyle social skills training,
maintenance, memory notebooks
and in some skills training, and
cases AChE goal-planning skills
inhibitors and
Namenda”
Tsolaki et al. (2011); RCT MCIa (n = MCIa Recruitment: 751 Cognitive training 5-month intervention Intervention end Global cognitive improvements
Greece 104) Waitlist (n = approached, 575 excluded (attention and period
72) (182 travel restrictions, 8 executive function), 90 minutes per
died, 12 medical problem, cognitive stimulation session, 3 sessions a
321 dementia, 52 on (enhancement of day (1 of each
AChEI), 176 enrolled episodic memory, component), 1
Attrition: No information semantic memory, session per week, 60
autobiographical sessions total (20
memory, mental sessions of each
imagery, and visual component)
memory), and
psychotherapeutic
techniques
(relaxation)
AChEI = Acetylcholinesterase inhibitor. aMCI = Mild cognitive impairment, amnestic subtype. CG = Control group. CT = Controlled trial. IG = Intervention group. MCI = Mild cognitive impairment. RCT
= Randomized controlled trial.
Table 6
Note. Measures are provided with + or − to reflect whether it was reported as significantly different in the study. When it was possible to calculate effect size, those numbers are provided next to the relevant
test (effect size, final number of participants treated by that time point, final number of comparison participants by that time point, positive effect sizes reflect greater improvement for treatment group
Chandler et al.
relative to comparison group). Cohen’s d effect size computed as [(posttesttreatment − pretesttreatment) − (posttestcontrol − pretestcontrol)]/(pooled baseline standard deviation of both groups). Outcomes
without an effect size did not provide information necessary to compute standardized mean differences.
*
Study-specific measure.
**
Effect sizes computed as group differences in Cohen’s d for published posttest-pretest changes.
***
Reported by caregiver in reference to the patient.
Measures: ADCS-MCI-ADL (Alzheimer’s Disease Cooperative Study MCI Activities of Daily Living Scale; Galasko et al. 1997); ADL-PI (Activities of Daily Living-Prevention Instrument; Galasko et al.
2006); BADL (Bayer-Activities of Daily Living; Hindmarch et al. 1998); BDI-G (Beck Depression Inventory-German version; Hautzinger et al. 1994); CDAD (Chinese Disability Assessment for Dementia;
Mok et al. 2005); CDR (Clinical Dementia Rating; Morris 1997); CSDD (Cornell Scale for Depression in Dementia; C. Lam et al. 2004); CSE (Coping Self-efficacy Scale; Chesney et al. 2006); EFPT
(Executive Function Performance Test; Baum et al. 2007): FRSSD (Functional Rating Scale of Dementia; Hutton 1990); GDS (Geriatric Depression Scale; Yesavage et al. 1983); GDS-15 (Geriatric
Depression Scale-15 item; Herrmann et al. 1996); GDS-SF (Geriatric Depression Scale-Short form; Sheikh et al. 1986); ICQ (Illness Cognition Questionnaire; Evers et al. 2001); IQCODE (Informant
Questionnaire on Cognitive Decline in the Elderly; De Jonghe et al. 1997); KQOL-AD (Korean Quality of Life-Alzheimer’s Disease; Shin 2006); LIADL (Lawton Instrumental Activities of Daily Living
Scale Hong Kong; Tong and Man 2002); MIC (Memory Inventory for Chinese; Cheong et al. 2006); MMAA (Medication Management Ability Assessment; Patterson et al. 2002); PDQ-39 (Parkinson’s
Disease Questionnaire; Jenkinson et al. 1995); RAND-36-Dutch (Van der Zee and Sanderman 1993); RMBPC (Revised Memory and Behavioral Problems Checklist-Dutch; Teunisse et al. 1997); SCQ
(Sense of Competence Questionnaire; Vernooij-Dassen et al. 1996).
Table 7
Group k d 95% CI τ2 p(Q) Fail Safe N Begg and Mazumdar’s rank correlation (p-value) V&W 1 V&W 2 V&W 3 V&W 4
Chandler et al.
Intervention Modality
Computer 15 0.31 0.12 – 0.51 0.00 .56 40 .00 (1.00) 0.24 0.13 0.28 0.23
Therapist 57 0.20 0.11 – 0.30 0.04 .43 618 .30 (< .001) 0.12 −0.82 0.17 0.14
Multimodal 19 0.31 0.08 – 0.54 0.19 .69 219 .12 (.48) 0.19 −0.96 0.27 0.23
Outcome Type
Mood 26 0.16 0.03 – 0.28 0.02 .44 74 .26 (.07) 0.09 0.02 0.12 0.11
Metacognition 24 0.37 0.15 – 0.58 0.16 .88 301 .22 (.14) 0.23 −0.88 0.29 0.20
ADL 31 0.32 0.16 – 0.47 0.09 .65 366 .10 (.43) 0.21 −0.90 0.27 0.21
QOL 10 0.06 −0.11 – 0.22 0.00 .44 −9 −.11 (.66) −0.00 −0.54 0.04 0.03
Note. k = number of outcomes included in this category; individual studies could contribute multiple outcomes; see Table 7 for classification of, and specific outcomes contributed by, each study; d =
standardized mean difference in improvement for treatment minus comparison group. Positive values indicate greater improvement in the treatment group; 95% CI = estimated 95% confidence interval of
the standardized mean difference; τ2 = tau squared, a random effects estimate of the between-outcome heterogeneity in effect size, with larger values representing greater heterogeneity; p(Q) = probability
associated with a random effects test of the null hypothesis of homogeneity, with non-significant values (p > .05) suggesting that we cannot reject the null hypothesis of homogeneous effect sizes among
studies in this intervention modality; Rosenthal’s (1979) Fail Safe N is the estimated number of studies that would need to exist to turn a significant population effect size estimate into a non-significant one;
strong/significant Begg & Mazumdar’s (1994) correlation coefficients are indicative of greater bias; V&W: Vevea and Woods (2005) adjusted effect size estimates under four conditions: 1 = Moderate one-
tailed selection, 2 = Severe one-tailed selection, 3 = Moderate two-tailed selection, and 4 = Severe two-tailed selection. All publication bias statistics were estimated under random effects models.